Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice

Journal of Clinical Investigation

Volumn 113, Issue 10, 2004, Pages 1398-1407

  Iglesias, Ainhoa ^a   Murga, Matilde ^a,g   Laresgoiti, Usua ^a   Skoudy, Anouchka ^b   Bernales, Irantzu ^a   Fullaondo, Asier ^a   Moreno, Bernardino ^c   Lloreta, José ^d   Field, Seth J ^e,f   Real, Francisco X ^b   Zubiaga, Ana M ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c NEIKER and a Vaccine producing Commercial Company CZVSL   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; E2F1 PROTEIN, MOUSE; E2F2 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

ACINAR CELL; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL COUNT; CELL CYCLE; CELL GROWTH; CELL SIZE; CONTROLLED STUDY; DIABETES MELLITUS; DNA REPLICATION; DOWN REGULATION; DYSPLASIA; ENDOCRINE CELL; EXOCRINE CELL; GENE EXPRESSION REGULATION; IN VIVO STUDY; INSULIN DEFICIENCY; MARKER GENE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS DUCT; PANCREAS INSUFFICIENCY; PANCREAS ISLET CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION; ANIMAL; CELL DIFFERENTIATION; CELL DIVISION; ELECTRON MICROSCOPY; GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE MUTANT; PANCREAS; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS ISLET; PATHOLOGY;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; DIABETES MELLITUS, TYPE 1; DNA REPLICATION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; E2F2 TRANSCRIPTION FACTOR; EXOCRINE PANCREATIC INSUFFICIENCY; ISLETS OF LANGERHANS; MALE; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; PANCREAS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 2942596505     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200418879     Document Type: Article

References (46)

1. Boyd, K.E., and Farnham, P.J. 1999. Identification of target genes of oncogenic transcription factors. Proc. Soc. Exp. Biol. Med. 222:9-28.
2. Dyson, N. 1998. The regulation of E2F by pRb-family proteins. Genes Dev. 12:2245-2262.
3. Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:28-35.
4. DeGregori, J. 2002. The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim. Biophys. Acta. 1602:131-150.
5. Ishida, S., et al. 2001. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell. Biol. 21:4684-4699.
6. Müller, H., et al. 2001. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15:267-285.
7. Ren, B., et al. 2002. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev. 16:245-256.
8. Weinmann, A.S., Yan, P.S., Oberley, M.J., Huang, T.H., and Farnham, P.J. 2002. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev. 16:235-244.
9. Takahashi, Y., Rayman, J.B., and Dynlacht, B.D. 2000. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 14:804-816.
10. Wells, J., Boyd, K.E., Fry, C.J., Bartley, S.M., and Farnham, P.J. 2000. Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell. Biol. 20:5797-5807.
11. Field, S.J., et al. 1996. E2F1 functions in mice to promote apoptosis and suppress proliferation. Cell. 85:549-561.
12. Yamasaki, L., et al. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell. 85:537-548.
13. Zhu, J.W., DeRyckere, D., Li, F.X., Wan, Y.Y., and DeGregori, J. 1999. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ. 10:829-838.
14. Garcia, I., Murga, M., Vicario, A., Field, S.J., and Zubiaga, A.M. 2000. A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ. 11:91-98.
15. Murga, M., et al. 2001. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity. 15:959-970.
16. Zhu, J.W., et al. 2001. E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol. Cell. Biol. 21:8547-8564.
17. Humbert, P.O., et al. 2000. E2F3 is critical for normal cellular proliferation. Genes Dev. 14:690-703.
18. Humbert, P.O., et al. 2000. E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol. Cell. 6:281-291.
19. Rempel, R.E., et al. 2000. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. Mol. Cell. 6:293-306.
20. Lindeman, G.J., et al. 1998. A specific, nonproliferative role for E2F-5 in choroids plexus function revealed by gene targeting. Genes Dev. 12:1092-1098.
21. Wells, J., Graveel, C.R., Bartley, S.M., Madore, S.J., and Farnham, P.J. 2002. The identification of E2F1-specific target genes. Proc. Natl. Acad. Sci. U. S. A. 99:3890-3895.
22. Cloud, J.E., et al. 2002. Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo. Mol. Cell Biol. 22:2663-2672.
23. Wu, L., et al. 2001. The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 414:457-462.
24. Heller, R.S., et al. 2001. Improved glucose tolerance and acinar dysmorphogenesis by targeted expression of transcription factor PDX-1 to the exocrine pancreas. Diabetes. 50:1553-1561.
25. Nicoletti, F., et al. 2000. Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin. J. Autoimmun. 15:395-405.
26. Rane, S.G., et al. 1999. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nat. Genet. 22:44-52.
27. Garofalo, R.S., et al. 2003. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ. J. Clin. Invest. 112:197-208. doi:10.1172/JCI20031688S.
28. Suzuki, A., and Hemmati-Brivanlou, A. 2000. Xenopus embryonic E2F is required for the formation of ventral and posterior cell fates during early embryogenesis. Mol. Cell. 5:217-229.
29. Edlund, H. 1998. Transcribing pancreas. Diabetes. 47:1817-1823.
30. Kawaguchi, Y., et al. 2002. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat. Genet. 32:128-134.
31. Sidorova, J.M., and Breeden, L.L. Precocious S-phase entry in budding yeast prolongs replicative state and increases dependence upon Rad53 for viability. Genetics. 160:123-136.
32. Watanabe, K., Morishita, J., Umezu, K., Shirahige, K., and Maki, H. 2002. Involvement of Rad9-dependent damage checkpoint control in arrest of cell cycle, induction of cell death, and chromosome instability caused by defects in origin recognition complex in Saccharomyces cerevisiae. Eukaryot. Cell. 1:200-212.
33. Li, F.X., Zhu, J.W., Hogan, C.J., and DeGregori, J. Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice. Mol. Cell. Biol. 23:3607-3622.
34. Rozenblum, E., et al. 1997. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 57:1731-1734.
35. Bardeesy, N., and DePinho, R.A. 2002. Pancreatic cancer biology and genetics. Nat. Rev. Cancer. 2:897-909.
36. Johnson, D.G., Schwarz, J.K., Cress, W.D., and Nevins, J.R. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature. 365:349-352.
37. Lees, J.A., et al. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13:7813-7825.
38. Lukas, J., Petersen, B.O., Holm, K., Bartek, J., and Helin, K. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16:1047-1057.
39. Harbour, J.W., and Dean, D.C. 2000. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14:2393-2409.
40. Whitcomb, D.C. 2001. Hereditary pancreatitis: a model for understanding the genetic basis of acute and chronic pancreatitis. Pancreatology. 1:565-570.
41. Zenilman, M.E., Tuchman, D., Zheng, Q., Levine, J., and Delany, H. 2000. Comparison of reg I and reg III levels during acute pancreatitis in the rat. Ann. Surg. 232:646-652.
42. Graf, R., Schiesser, M., Lussi, A., Went, P., Scheele, G.A., and Bimmler, D. 2002. Coordinate regulation of secretory stress proteins (PSP/reg, PAP I, PAP II, and PAP III) in the rat exocrine pancreas during experimental acute pancreatitis. J. Surg. Res. 105:136-144.
43. Fishman, M.P., and Melton, D.A. 2002. Pancreatic lineage analysis using a retroviral vector in embryonic mice demonstrates a common progenitor for endocrine and exocrine cells. Int. J. Dev. Biol. 46:201-207.
44. Bonner-Weir, S., and Shama, A. 2002. Pancreatic stem cells. J. Pathol. 197:519-526.
45. Vilá, M.R., Lloreta, J., and Real, F.X. 1994. Normal human pancreas cultures display functional ductal characteristics. Lab. Invest. 71:423-431.
46. Li, F.X., et al. 2003. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc. Natl. Acad. Sci. U.S.A. 100:12935-12940.